N/A
Completed N=18
Distribution of Topical Nasal Medication Within the Nasal Cavity and Sinuses by Radiographic Comparison
Chronic Sinusitis
Source: ClinicalTrials.gov NCT00626366 ↗
Enrolled (actual)
18
Serious AEs
0.0%
Results posted
Aug 2019
Primary outcomePrimary: To Measure the Distribution of Nasal Sprays and Drops. — 18; 17; 16; 17 nasal cavities (right and left sides)
Summary
The purpose of this study is to determine the distribution of nasal sprays and nasal drops when used.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY To Measure the Distribution of Nasal Sprays and Drops. |
18; 17; 16; 17; 0; 6 | — |
Eligibility Criteria
Inclusion Criteria
- adult able to perform activities of daily living
Exclusion Criteria
- signs or symptoms of acute or chronic paranasal sinus disease
- history of sinus surgery
- symptomatic deviated septum
- active seasonal allergies
- allergies to contrast
- history of nasal polyposis
- pregnant or breast feeding women
- neck or back problems that would prevent a subject from kneeling on the floor and crouching over
- currently taking metformin or amiodarone
- students or stff under the direct supervision of the investigators
- cognitive impairment
- terminal illness
Data sourced from ClinicalTrials.gov (NCT00626366). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.